PTPA and colorectal carcinoma: This issue was concordant with the ability of this miR to modulate PP2A activity (Figure 2C and Figure S3), suggesting that miR-19b overexpression could represent a molecular alteration responsible of the PPP2R5E downregulation previously identified in CRC patients [32], which should be investigated in forthcoming studies.